Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 60
- Locations
- 4
- Primary Endpoint
- retention in treatment, cocaine abstinence
Study Overview
Brief Summary
The purpose of this study is to determine whether prize-based contingency management (prizeCM) combined with cognitive behavioral therapy (CBT) is more effective in the treatment of of cocaine-dependent patients compared to CBT only. Patients were randomized to prizeCM + CBT (experimental group) or to CBT (control group) an treated over 24 weeks. It is the first trial of this type in Europe.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •cocaine dependence, aged 18 or older, other dependences
Exclusion Criteria
- •severe somatic, brain, or psychiatric disease, attention deficit disorders with medication methylphenidate
Outcomes
Primary Outcomes
retention in treatment, cocaine abstinence
Time Frame: 24 weeks
cocaine abstinence: at least 3 consecutive weeks of cocaine abstinence, the maximum number of weeks of continous abstinence and proportions of cocaine-free urine samples during the entire 24-week and at 6-month follow-up.
Secondary Outcomes
- patients' satisfaction with the therapy, clinical measures(24 weeks)
Investigators
Sylvie Petitjean
Dr. phil
University Hospital, Basel, Switzerland
